Efficient Nose-to-Lung Aerosol Delivery with an Inline DPI Requiring Low Actuation Air Volume

Purpose To demonstrate efficient aerosol delivery through an in vitro nasal model using a dry powder inhaler (DPI) requiring low actuation air volumes (LV) applied during low-flow nasal cannula (LFNC) therapy. Methods A previously developed LV-DPI was connected to a LFNC system with 4 mm diameter tu...

Full description

Saved in:
Bibliographic Details
Published inPharmaceutical research Vol. 35; no. 10; pp. 194 - 12
Main Authors Farkas, Dale, Hindle, Michael, Longest, P. Worth
Format Journal Article
LanguageEnglish
Published New York Springer US 01.10.2018
Springer
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Purpose To demonstrate efficient aerosol delivery through an in vitro nasal model using a dry powder inhaler (DPI) requiring low actuation air volumes (LV) applied during low-flow nasal cannula (LFNC) therapy. Methods A previously developed LV-DPI was connected to a LFNC system with 4 mm diameter tubing. System connections and the nasal cannula interface were replaced with streamlined components. To simulate nasal respiration, an in vitro nasal model was connected to a downstream lung simulator that produced either passive or deep nasal respiration. Performance of a commercial mesh nebulizer system was also considered. Results For the optimized system, steady state cannula emitted dose was 75% of the capsule loaded dose. With cyclic nasal breathing, delivery efficiency to the tracheal filter was 53–55% of the loaded dose, which was just under the design target of 60%. Compared with a commercially available mesh nebulizer, the optimal LV-DPI was 40-fold more efficient and 150 times faster in terms of delivering aerosol to the lungs. Conclusions The optimized LV-DPI system is capable of high efficiency lung delivery of powder aerosols through a challenging nasal cannula interface.
AbstractList Purpose To demonstrate efficient aerosol delivery through an in vitro nasal model using a dry powder inhaler (DPI) requiring low actuation air volumes (LV) applied during low-flow nasal cannula (LFNC) therapy. Methods A previously developed LV-DPI was connected to a LFNC system with 4 mm diameter tubing. System connections and the nasal cannula interface were replaced with streamlined components. To simulate nasal respiration, an in vitro nasal model was connected to a downstream lung simulator that produced either passive or deep nasal respiration. Performance of a commercial mesh nebulizer system was also considered. Results For the optimized system, steady state cannula emitted dose was 75% of the capsule loaded dose. With cyclic nasal breathing, delivery efficiency to the tracheal filter was 53–55% of the loaded dose, which was just under the design target of 60%. Compared with a commercially available mesh nebulizer, the optimal LV-DPI was 40-fold more efficient and 150 times faster in terms of delivering aerosol to the lungs. Conclusions The optimized LV-DPI system is capable of high efficiency lung delivery of powder aerosols through a challenging nasal cannula interface.
PURPOSETo demonstrate efficient aerosol delivery through an in vitro nasal model using a dry powder inhaler (DPI) requiring low actuation air volumes (LV) applied during low-flow nasal cannula (LFNC) therapy. METHODSA previously developed LV-DPI was connected to a LFNC system with 4 mm diameter tubing. System connections and the nasal cannula interface were replaced with streamlined components. To simulate nasal respiration, an in vitro nasal model was connected to a downstream lung simulator that produced either passive or deep nasal respiration. Performance of a commercial mesh nebulizer system was also considered. RESULTSFor the optimized system, steady state cannula emitted dose was 75% of the capsule loaded dose. With cyclic nasal breathing, delivery efficiency to the tracheal filter was 53-55% of the loaded dose, which was just under the design target of 60%. Compared with a commercially available mesh nebulizer, the optimal LV-DPI was 40-fold more efficient and 150 times faster in terms of delivering aerosol to the lungs. CONCLUSIONSThe optimized LV-DPI system is capable of high efficiency lung delivery of powder aerosols through a challenging nasal cannula interface.
To demonstrate efficient aerosol delivery through an in vitro nasal model using a dry powder inhaler (DPI) requiring low actuation air volumes (LV) applied during low-flow nasal cannula (LFNC) therapy. A previously developed LV-DPI was connected to a LFNC system with 4 mm diameter tubing. System connections and the nasal cannula interface were replaced with streamlined components. To simulate nasal respiration, an in vitro nasal model was connected to a downstream lung simulator that produced either passive or deep nasal respiration. Performance of a commercial mesh nebulizer system was also considered. For the optimized system, steady state cannula emitted dose was 75% of the capsule loaded dose. With cyclic nasal breathing, delivery efficiency to the tracheal filter was 53-55% of the loaded dose, which was just under the design target of 60%. Compared with a commercially available mesh nebulizer, the optimal LV-DPI was 40-fold more efficient and 150 times faster in terms of delivering aerosol to the lungs. The optimized LV-DPI system is capable of high efficiency lung delivery of powder aerosols through a challenging nasal cannula interface.
Purpose To demonstrate efficient aerosol delivery through an in vitro nasal model using a dry powder inhaler (DPI) requiring low actuation air volumes (LV) applied during low-flow nasal cannula (LFNC) therapy. Methods A previously developed LV-DPI was connected to a LFNC system with 4 mm diameter tubing. System connections and the nasal cannula interface were replaced with streamlined components. To simulate nasal respiration, an in vitro nasal model was connected to a downstream lung simulator that produced either passive or deep nasal respiration. Performance of a commercial mesh nebulizer system was also considered. Results For the optimized system, steady state cannula emitted dose was 75% of the capsule loaded dose. With cyclic nasal breathing, delivery efficiency to the tracheal filter was 53-55% of the loaded dose, which was just under the design target of 60%. Compared with a commercially available mesh nebulizer, the optimal LV-DPI was 40-fold more efficient and 150 times faster in terms of delivering aerosol to the lungs. Conclusions The optimized LV-DPI system is capable of high efficiency lung delivery of powder aerosols through a challenging nasal cannula interface.
ArticleNumber 194
Audience Academic
Author Farkas, Dale
Longest, P. Worth
Hindle, Michael
AuthorAffiliation 1 Department of Mechanical and Nuclear Engineering, Virginia Commonwealth University, Richmond, VA
2 Department of Pharmaceutics, Virginia Commonwealth University, Richmond, VA
AuthorAffiliation_xml – name: 2 Department of Pharmaceutics, Virginia Commonwealth University, Richmond, VA
– name: 1 Department of Mechanical and Nuclear Engineering, Virginia Commonwealth University, Richmond, VA
Author_xml – sequence: 1
  givenname: Dale
  surname: Farkas
  fullname: Farkas, Dale
  organization: Department of Mechanical and Nuclear Engineering, Virginia Commonwealth University
– sequence: 2
  givenname: Michael
  surname: Hindle
  fullname: Hindle, Michael
  organization: Department of Pharmaceutics, Virginia Commonwealth University Richmond
– sequence: 3
  givenname: P. Worth
  surname: Longest
  fullname: Longest, P. Worth
  email: pwlongest@vcu.edu
  organization: Department of Mechanical and Nuclear Engineering, Virginia Commonwealth University, Department of Pharmaceutics, Virginia Commonwealth University Richmond
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30132207$$D View this record in MEDLINE/PubMed
BookMark eNp1kV1vFCEUhompsdvqD_DGkHjTm6kH5oPhxmTTVt1ko8ao8cYQljlsaWZgCzNt-u9lnVo_EsMFBJ7zwuE5Igc-eCTkOYNTBiBeJcZA1gWwtuCVKAvxiCxYnRcSqm8HZAGCV0UrKnZIjlK6AoCWyeoJOSyBlZyDWJDvF9Y649CP9H1IWIyhWE9-S5cYQwo9Pcfe3WC8o7duvKTa05XvnUd6_nFFP-H15KLL9Drc0qUZJz264OnSRfo19NOAT8ljq_uEz-7nY_LlzcXns3fF-sPb1dlyXZga5FjUHZQbkBJ5zXXT2NborgM0QmvettDqWnNblo2xrOkaK4UsNxY1QmeEqTdQHpPXc-5u2gzYmdxO1L3aRTfoeKeCdurvE-8u1TbcKMHrktUsB5zcB8RwPWEa1eCSwb7XHsOUFAfJWs4YLzP68h_0KkzR5_Z-UsClaGWmTmdqq3tUztuQ7zV5dDg4kzVal_eXWRBnwOp9C2wuMPnjU0T78HoGam9bzbZVtq32tpXINS_-bPuh4pfeDPAZSLu9J4y_3_r_1B-GQ7bj
CitedBy_id crossref_primary_10_1007_s11095_020_02806_y
crossref_primary_10_1089_jamp_2018_1488
crossref_primary_10_1007_s11095_021_03094_w
crossref_primary_10_1016_j_jaerosci_2020_105692
crossref_primary_10_1021_acs_molpharmaceut_3c00007
crossref_primary_10_1208_s12249_020_01667_3
crossref_primary_10_1007_s11095_019_2644_1
crossref_primary_10_1007_s11095_022_03316_9
crossref_primary_10_1208_s12248_018_0281_y
crossref_primary_10_1089_jamp_2019_1540
crossref_primary_10_1089_jamp_2020_1604
crossref_primary_10_1016_j_ijpharm_2023_123138
crossref_primary_10_1089_jamp_2021_0057
crossref_primary_10_1208_s12249_019_1535_4
crossref_primary_10_1007_s11095_022_03180_7
crossref_primary_10_1016_j_jaerosci_2023_106262
crossref_primary_10_1016_j_ijpharm_2023_123199
crossref_primary_10_1016_j_addr_2022_114461
crossref_primary_10_1007_s11095_020_02889_7
Cites_doi 10.1089/jam.1989.2.365
10.1080/027868290883432
10.1089/jam.2006.19.301
10.1080/02786826.2014.887829
10.1089/jamp.2016.1320
10.1089/jamp.2010.0849
10.1089/jamp.2012.0997
10.1089/jamp.2017.1366
10.1089/jamp.2011.0929
10.1016/j.ijpharm.2014.01.043
10.1007/s11095-013-1165-6
10.1016/j.ijpharm.2013.12.030
10.1089/jamp.2007.0662
10.1002/jps.23775
10.1089/jamp.2014.1158
10.1016/j.ijpharm.2017.08.079
10.1080/027868290883360
10.1089/jam.2007.0574
10.1007/s10439-013-0759-9
10.1007/s11095-013-1123-3
10.1016/S0140-6736(81)90002-7
10.1089/jamp.2016.1333
10.1097/PCC.0b013e31828a7f79
10.1089/jamp.2016.1343
10.1007/s10439-006-9245-y
10.1007/s10439-015-1335-2
10.1080/02786826.2011.566592
10.1111/j.2042-7158.2012.01476.x
10.1016/j.ijpharm.2013.01.003
10.1136/thx.51.1.75
10.4187/respcare.02782
10.1080/02786820902950887
10.1016/j.rmed.2005.07.012
10.1016/j.ijheatmasstransfer.2008.04.037
10.1080/02786826.2011.643257
10.4187/respcare.01941
10.1002/ppul.23123
10.1089/jamp.2017.1424
10.1016/j.ijpharm.2018.05.011
10.1089/jamp.2010.0825
ContentType Journal Article
Copyright Springer Science+Business Media, LLC, part of Springer Nature 2018
COPYRIGHT 2018 Springer
Pharmaceutical Research is a copyright of Springer, (2018). All Rights Reserved.
Copyright_xml – notice: Springer Science+Business Media, LLC, part of Springer Nature 2018
– notice: COPYRIGHT 2018 Springer
– notice: Pharmaceutical Research is a copyright of Springer, (2018). All Rights Reserved.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7RV
7TK
7X7
7XB
88E
8AO
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
CCPQU
FYUFA
GHDGH
K9.
KB0
M0S
M1P
NAPCQ
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOI 10.1007/s11095-018-2473-7
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
ProQuest Nursing & Allied Health Database
Neurosciences Abstracts
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
AUTh Library subscriptions: ProQuest Central
ProQuest One Community College
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Nursing & Allied Health Premium
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Pharma Collection
Neurosciences Abstracts
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE

ProQuest One Academic Eastern Edition
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: AUTh Library subscriptions: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1573-904X
EndPage 12
ExternalDocumentID A724210150
10_1007_s11095_018_2473_7
30132207
Genre Journal Article
GrantInformation_xml – fundername: Eunice Kennedy Shriver National Institute of Child Health and Human Development
  grantid: HD087339
  funderid: http://dx.doi.org/10.13039/100009633
– fundername: National Heart, Lung, and Blood Institute
  grantid: HL139673
  funderid: http://dx.doi.org/10.13039/100000050
– fundername: NICHD NIH HHS
  grantid: R01 HD087339
– fundername: NHLBI NIH HHS
  grantid: R01 HL139673
– fundername: Eunice Kennedy Shriver National Institute of Child Health and Human Development
  grantid: HD087339
– fundername: NHLBI NIH HHS
  grantid: HL139673
GroupedDBID ---
-4W
-56
-5G
-BR
-EM
-Y2
-~C
.86
.VR
06C
06D
0R~
0VY
123
199
1N0
1SB
2.D
203
28-
29O
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
3SX
3V.
4.4
406
408
409
40D
40E
53G
5QI
5VS
67N
67Z
6NX
78A
7RV
7X7
88E
8AO
8FI
8FJ
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AABYN
AAFGU
AAHNG
AAIAL
AAJKR
AANXM
AANZL
AAPBV
AARHV
AARTL
AATNV
AATVU
AAUYE
AAWCG
AAYFA
AAYIU
AAYOK
AAYQN
AAYTO
ABBBX
ABBXA
ABDZT
ABECU
ABELW
ABFGW
ABFTV
ABHLI
ABHQN
ABIPD
ABJNI
ABJOX
ABKAS
ABKCH
ABKTR
ABLJU
ABMNI
ABMQK
ABNWP
ABPLI
ABPTK
ABQBU
ABSXP
ABTEG
ABTHY
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACBMV
ACBRV
ACBXY
ACBYP
ACGFS
ACHSB
ACHXU
ACIGE
ACIPQ
ACIWK
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPRK
ACTTH
ACVWB
ACWMK
ADBBV
ADHHG
ADHIR
ADIMF
ADINQ
ADJJI
ADKNI
ADKPE
ADMDM
ADOAH
ADOXG
ADRFC
ADTPH
ADURQ
ADYFF
ADYPR
ADZKW
AEBTG
AEEQQ
AEFIE
AEFTE
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AENEX
AEOHA
AEPYU
AESKC
AESTI
AETLH
AEVLU
AEVTX
AEXYK
AFDYV
AFEXP
AFGCZ
AFKRA
AFLOW
AFNRJ
AFQWF
AFRAH
AFWTZ
AFZKB
AGAYW
AGDGC
AGGBP
AGGDS
AGJBK
AGMZJ
AGQMX
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHKAY
AHMBA
AHSBF
AHYZX
AIAKS
AIIXL
AILAN
AIMYW
AITGF
AJBLW
AJDOV
AJRNO
AJZVZ
AKMHD
AKQUC
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
AOSHJ
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
B-.
BA0
BBWZM
BDATZ
BENPR
BGNMA
BKEYQ
BPHCQ
BVXVI
CAG
CCPQU
COF
CS3
CSCUP
DDRTE
DL5
DNIVK
DPUIP
DU5
EBD
EBLON
EBS
EIOEI
EJD
EMOBN
EN4
EPAXT
ESBYG
EX3
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GQ8
GXS
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IAO
IHE
IJ-
IKXTQ
IMOTQ
INH
ITM
IWAJR
IXC
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KOW
KPH
L7B
LAK
LLZTM
LSO
M1P
M4Y
MA-
MK0
N2Q
N9A
NAPCQ
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
OVD
P19
P2P
PF0
PQQKQ
PROAC
PSQYO
PT4
PT5
Q2X
QOK
QOR
QOS
R4E
R89
R9I
RHV
RIG
RNI
RNS
ROL
RPX
RRX
RSV
RZC
RZE
RZK
S16
S1Z
S26
S27
S28
S3A
S3B
SAP
SBL
SBY
SCLPG
SDH
SHX
SISQX
SJYHP
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZN
T13
T16
TEORI
TSG
TSK
TSV
TUC
U2A
U9L
UG4
UKHRP
UNUBA
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WH7
WJK
WK6
WK8
WOW
YCJ
YLTOR
Z45
Z5O
Z7S
Z7U
Z7V
Z7W
Z7X
Z81
Z82
Z83
Z84
Z87
Z88
Z8N
Z8O
Z8P
Z8Q
Z8R
Z8V
Z8W
Z91
Z92
ZGI
ZMTXR
ZOVNA
~KM
AACDK
AAJBT
AASML
AAYZH
ABAKF
ACAOD
ACDTI
ACZOJ
AEFQL
AEMSY
AFBBN
AGQEE
AGRTI
AIGIU
ALIPV
CGR
CUY
CVF
ECM
EIF
H13
NPM
AAEOY
AAQLM
AAYXX
CITATION
7TK
7XB
8FK
K9.
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c509t-5d03b099e252a66f8cadd0ec7aa28808a5a2f336cf16d6f9793bfeae0dc7c5b03
IEDL.DBID BENPR
ISSN 0724-8741
IngestDate Tue Sep 17 21:23:08 EDT 2024
Fri Aug 16 01:25:06 EDT 2024
Thu Oct 10 19:16:05 EDT 2024
Fri Feb 02 04:30:08 EST 2024
Fri Sep 13 09:29:01 EDT 2024
Wed Oct 16 00:45:06 EDT 2024
Sat Dec 16 11:59:17 EST 2023
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 10
Keywords low flow oxygen
nasal cannula aerosol
pharmaceutical aerosol
inline DPI
low flow nasal cannula
Dry powder inhaler (DPI)
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c509t-5d03b099e252a66f8cadd0ec7aa28808a5a2f336cf16d6f9793bfeae0dc7c5b03
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7253151
PMID 30132207
PQID 2091029789
PQPubID 37334
PageCount 12
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_7253151
proquest_miscellaneous_2091821123
proquest_journals_2091029789
gale_infotracacademiconefile_A724210150
crossref_primary_10_1007_s11095_018_2473_7
pubmed_primary_30132207
springer_journals_10_1007_s11095_018_2473_7
PublicationCentury 2000
PublicationDate 2018-10-01
PublicationDateYYYYMMDD 2018-10-01
PublicationDate_xml – month: 10
  year: 2018
  text: 2018-10-01
  day: 01
PublicationDecade 2010
PublicationPlace New York
PublicationPlace_xml – name: New York
– name: United States
PublicationSubtitle An Official Journal of the American Association of Pharmaceutical Scientists
PublicationTitle Pharmaceutical research
PublicationTitleAbbrev Pharm Res
PublicationTitleAlternate Pharm Res
PublicationYear 2018
Publisher Springer US
Springer
Springer Nature B.V
Publisher_xml – name: Springer US
– name: Springer
– name: Springer Nature B.V
References Xi, Longest (CR32) 2007; 35
CR19
Dugernier, Hesse, Jumetz, Bialais, Roeseler, Depoortere, Michotte, Wittebole, Ehrmann, Laterre (CR36) 2017; 30
CR18
Zeman, Rojas Balcazar, Fuller, Donn, Boucher, Bennett, Donaldson (CR37) 2017; 30
Franca, de Andrade, Cabral, Almeida, Silva, Galindo, Marinho, Lemos, Parreira (CR34) 2006; 100
Kelly, Asgharian, Kimbell, Wong (CR26) 2004; 38
Schroeter, Kimbell, Asgharian (CR29) 2006; 19
Longest, Hindle (CR42) 2011; 45
Longest, Golshahi, Hindle (CR20) 2013; 41
Longest, Golshahi, Behara, Tian, Farkas, Hindle (CR8) 2015; 28
Perry, Kesser, Geller, Selhorst, Rendle, Hertzog (CR17) 2013; 14
Behara, Longest, Farkas, Hindle (CR38) 2014; 103
Son, Longest, Hindle (CR35) 2013; 443
Longest, Azimi, Golshahi, Hindle (CR22) 2014; 59
Pornputtapitak, El-Gendy, Mermis, O'Brein-Ladner, Berkland (CR2) 2014; 462
Boc, Farkas, Longest, Hindle (CR40) 2018; 2
Behara, Longest, Farkas, Hindle (CR1) 2014; 465
Boc, Farkas, Longest, Hindle (CR41) 2018; 2
Ward (CR13) 2013; 58
CR3
Hess (CR14) 2007; 20
Guilmette, Wicks, Wolff (CR25) 1989; 2
CR6
Walenga, Longest, Kaviratna, Hindle (CR11) 2017; 30
CR5
Okuda, Tang, Yu, Finlay, Chan (CR12) 2017; 533
Bhashyam, Wolf, Marcinkowski, Saville, Thomas, Carcillo, Corcoran (CR15) 2008; 21
CR28
Xi, Longest (CR31) 2009; 43
Everard, Devadason, LeSouef (CR10) 1996; 51
Farkas, Hindle, Longest (CR39) 2015; 43
Morley, Miller, Bangham, Davis (CR9) 1981; 317
Xi, Longest (CR30) 2008; 51
Hindle, Longest (CR45) 2012; 64
Kelly, Asgharian, Kimbell, Wong (CR27) 2004; 38
Tian, Longest, Li, Hindle (CR44) 2013; 26
Longest, Tian, Hindle (CR21) 2011; 24
Feng, Tang, Leung, Dhanani, Chan (CR7) 2017; 30
Behara, Farkas, Hindle, Longest (CR23) 2014; 31
(CR33) 1994
Golshahi, Tian, Azimi, Son, Walenga, Longest, Hindle (CR24) 2013; 30
Dhand (CR16) 2012; 25
Laube, Sharpless, Shermer, Sullivan, Powell (CR4) 2012; 46
Tian, Hindle, Longest (CR43) 2014; 48
PW Longest (2473_CR8) 2015; 28
RL Walenga (2473_CR11) 2017; 30
DR Hess (2473_CR14) 2007; 20
J Xi (2473_CR31) 2009; 43
2473_CR28
JD Schroeter (2473_CR29) 2006; 19
SRB Behara (2473_CR23) 2014; 31
J Dugernier (2473_CR36) 2017; 30
SRB Behara (2473_CR1) 2014; 465
CJ Morley (2473_CR9) 1981; 317
JT Kelly (2473_CR26) 2004; 38
RA Guilmette (2473_CR25) 1989; 2
J Xi (2473_CR30) 2008; 51
SRB Behara (2473_CR38) 2014; 103
2473_CR5
ST Boc (2473_CR40) 2018; 2
2473_CR6
2473_CR3
R Dhand (2473_CR16) 2012; 25
AR Bhashyam (2473_CR15) 2008; 21
JJ Ward (2473_CR13) 2013; 58
Y-J Son (2473_CR35) 2013; 443
ICRP (2473_CR33) 1994
PW Longest (2473_CR20) 2013; 41
2473_CR18
PW Longest (2473_CR21) 2011; 24
G Tian (2473_CR43) 2014; 48
ML Everard (2473_CR10) 1996; 51
DR Farkas (2473_CR39) 2015; 43
2473_CR19
B Feng (2473_CR7) 2017; 30
J Xi (2473_CR32) 2007; 35
M Hindle (2473_CR45) 2012; 64
PW Longest (2473_CR42) 2011; 45
W Pornputtapitak (2473_CR2) 2014; 462
G Tian (2473_CR44) 2013; 26
JT Kelly (2473_CR27) 2004; 38
T Okuda (2473_CR12) 2017; 533
SA Perry (2473_CR17) 2013; 14
BL Laube (2473_CR4) 2012; 46
KL Zeman (2473_CR37) 2017; 30
PW Longest (2473_CR22) 2014; 59
ST Boc (2473_CR41) 2018; 2
EET Franca (2473_CR34) 2006; 100
L Golshahi (2473_CR24) 2013; 30
References_xml – volume: 2
  start-page: 365
  year: 1989
  end-page: 377
  ident: CR25
  article-title: Morphometry of human nasal airways in vivo using magnetic resonance imaging
  publication-title: J Aerosol Med
  doi: 10.1089/jam.1989.2.365
  contributor:
    fullname: Wolff
– volume: 38
  start-page: 1072
  year: 2004
  end-page: 1079
  ident: CR27
  article-title: Particle deposition in human nasal airway replicas manufactured by different methods. Part II: ultrafine particles
  publication-title: Aerosol Sci Technol
  doi: 10.1080/027868290883432
  contributor:
    fullname: Wong
– volume: 19
  start-page: 301
  year: 2006
  end-page: 313
  ident: CR29
  article-title: Analysis of particle deposition in the turbinate and olfactory regions using a human nasal computational fluid dynamics model
  publication-title: J Aerosol Med.
  doi: 10.1089/jam.2006.19.301
  contributor:
    fullname: Asgharian
– volume: 48
  start-page: 434
  year: 2014
  end-page: 449
  ident: CR43
  article-title: Targeted lung delivery of nasally administered aerosols
  publication-title: Aerosol Sci Technol
  doi: 10.1080/02786826.2014.887829
  contributor:
    fullname: Longest
– volume: 30
  start-page: 100
  year: 2017
  end-page: 107
  ident: CR7
  article-title: A novel in-line delivery system to administer dry powder mannitol to mechanically ventilated patients
  publication-title: J Aerosol Med Pulm Drug Deliv.
  doi: 10.1089/jamp.2016.1320
  contributor:
    fullname: Chan
– ident: CR18
– volume: 24
  start-page: 103
  year: 2011
  end-page: 118
  ident: CR21
  article-title: Improving the lung delivery of nasally administered aerosols during noninvasive ventilation - An application of enhanced condensational growth (ECG)
  publication-title: J Aerosol Med Pulm Drug Deliv
  doi: 10.1089/jamp.2010.0849
  contributor:
    fullname: Hindle
– volume: 2
  start-page: 635
  year: 2018
  end-page: 638
  ident: CR40
  article-title: Spray dried pulmonary surfactant powder formulations: Development and characterization
  publication-title: Respiratory Drug Delivery
  contributor:
    fullname: Hindle
– volume: 26
  start-page: 248
  year: 2013
  end-page: 265
  ident: CR44
  article-title: Targeting aerosol deposition to and within the lung airways using excipient enhanced growth
  publication-title: J Aerosol Med Pulm Drug Deliv
  doi: 10.1089/jamp.2012.0997
  contributor:
    fullname: Hindle
– volume: 30
  start-page: 349
  year: 2017
  end-page: 358
  ident: CR36
  article-title: Aerosol delivery with two nebulizers through high-flow nasal cannula: a randomized cross-over single-photon emission computed tomography-computed tomography study
  publication-title: Journal of Aerosol Medicine and Pulmonary Drug Delivery.
  doi: 10.1089/jamp.2017.1366
  contributor:
    fullname: Laterre
– volume: 25
  start-page: 63
  year: 2012
  end-page: 78
  ident: CR16
  article-title: Aerosol therapy in patients receiving noninvasive positive pressure ventilation
  publication-title: J Aerosol Med Pulm Drug Deliv.
  doi: 10.1089/jamp.2011.0929
  contributor:
    fullname: Dhand
– volume: 465
  start-page: 52
  year: 2014
  end-page: 62
  ident: CR1
  article-title: Development of high efficiency ventilation bag actuated dry powder inhalers
  publication-title: Int J Pharm
  doi: 10.1016/j.ijpharm.2014.01.043
  contributor:
    fullname: Hindle
– volume: 2
  start-page: 639
  year: 2018
  end-page: 642
  ident: CR41
  article-title: Aerosolization of spray dried pulmonary surfactant powder using a novel low air volume actuated dry powder inhaler
  publication-title: Respiratory Drug Delivery
  contributor:
    fullname: Hindle
– volume: 31
  start-page: 360
  year: 2014
  end-page: 372
  ident: CR23
  article-title: Development of a high efficiency dry powder inhaler: effects of capsule chamber design and inhaler surface modifications
  publication-title: Pharm Res
  doi: 10.1007/s11095-013-1165-6
  contributor:
    fullname: Longest
– volume: 462
  start-page: 19
  year: 2014
  end-page: 28
  ident: CR2
  article-title: NanoCluster budesondie formulations enable efficient drug delivery driven by mechanical ventilation
  publication-title: Int J Pharm
  doi: 10.1016/j.ijpharm.2013.12.030
  contributor:
    fullname: Berkland
– volume: 21
  start-page: 181
  year: 2008
  end-page: 187
  ident: CR15
  article-title: Aerosol delivery through nasal cannulas: an in vitro study
  publication-title: J Aerosol Med Pulm Drug Deliv.
  doi: 10.1089/jamp.2007.0662
  contributor:
    fullname: Corcoran
– ident: CR6
– volume: 103
  start-page: 465
  year: 2014
  end-page: 477
  ident: CR38
  article-title: Development and comparison of new high-efficiency dry powder inhalers for carrier-free formulations
  publication-title: J Pharm Sci
  doi: 10.1002/jps.23775
  contributor:
    fullname: Hindle
– volume: 28
  start-page: 189
  year: 2015
  end-page: 201
  ident: CR8
  article-title: Efficient nose-to-lung (N2L) aerosol delivery with a dry powder inhaler
  publication-title: J Aerosol Med Pulm Drug Deliv.
  doi: 10.1089/jamp.2014.1158
  contributor:
    fullname: Hindle
– volume: 533
  start-page: 187
  year: 2017
  end-page: 197
  ident: CR12
  article-title: Powder aerosol delivery through nasal high-flow system: in vitro feasibility and influence of process conditions
  publication-title: Int J Pharm
  doi: 10.1016/j.ijpharm.2017.08.079
  contributor:
    fullname: Chan
– volume: 38
  start-page: 1063
  year: 2004
  end-page: 1071
  ident: CR26
  article-title: Particle deposition in human nasal airway replicas manufactured by different methods. Part I: inertial regime particles
  publication-title: Aerosol Sci Technol
  doi: 10.1080/027868290883360
  contributor:
    fullname: Wong
– volume: 20
  start-page: S85
  year: 2007
  end-page: S99
  ident: CR14
  article-title: The mask of noninvasive ventilation: principles of design and effects on aerosol delivery
  publication-title: J Aerosol Med
  doi: 10.1089/jam.2007.0574
  contributor:
    fullname: Hess
– ident: CR19
– volume: 41
  start-page: 1217
  year: 2013
  end-page: 1232
  ident: CR20
  article-title: Improving pharmaceutical aerosol delivery during noninvasive ventilation: effects of streamlined components
  publication-title: Ann Biomed Eng
  doi: 10.1007/s10439-013-0759-9
  contributor:
    fullname: Hindle
– volume: 30
  start-page: 2917
  year: 2013
  end-page: 2930
  ident: CR24
  article-title: The use of condensational growth methods for efficient drug delivery to the lungs during noninvasive ventilation high flow therapy
  publication-title: Pharm Res
  doi: 10.1007/s11095-013-1123-3
  contributor:
    fullname: Hindle
– volume: 317
  start-page: 64
  year: 1981
  end-page: 68
  ident: CR9
  article-title: Dry artificial lung surfactant and its effect on very premature babies
  publication-title: Lancet
  doi: 10.1016/S0140-6736(81)90002-7
  contributor:
    fullname: Davis
– volume: 30
  start-page: 223
  year: 2017
  end-page: 229
  ident: CR37
  article-title: A trans-nasal aerosol delivery device for efficient pulmonary deposition
  publication-title: J Aerosol Med Pulm Drug Deliv.
  doi: 10.1089/jamp.2016.1333
  contributor:
    fullname: Donaldson
– volume: 14
  start-page: E250
  year: 2013
  end-page: E256
  ident: CR17
  article-title: Influences of cannula size and flow rate on aerosol drug delivery through the Vapotherm humidified high-flow nasal cannula system
  publication-title: Pediatr Crit Care Med
  doi: 10.1097/PCC.0b013e31828a7f79
  contributor:
    fullname: Hertzog
– volume: 30
  start-page: 190
  year: 2017
  end-page: 205
  ident: CR11
  article-title: Aerosol drug delivery during noninvasive positive pressure ventilation: effects of intersubject variability and excipient enhanced growth
  publication-title: J Aerosol Med Pulm Drug Deliv.
  doi: 10.1089/jamp.2016.1343
  contributor:
    fullname: Hindle
– ident: CR3
– volume: 35
  start-page: 560
  year: 2007
  end-page: 581
  ident: CR32
  article-title: Transport and deposition of micro-aerosols in realistic and simplified models of the oral airway
  publication-title: Ann Biomed Eng
  doi: 10.1007/s10439-006-9245-y
  contributor:
    fullname: Longest
– volume: 43
  start-page: 2804
  year: 2015
  end-page: 2815
  ident: CR39
  article-title: Characterization of a new high-dose dry powder inhaler (DPI) based on a fluidized bed design
  publication-title: Ann Biomed Eng
  doi: 10.1007/s10439-015-1335-2
  contributor:
    fullname: Longest
– volume: 45
  start-page: 884
  year: 2011
  end-page: 899
  ident: CR42
  article-title: Numerical model to characterize the size increase of combination drug and hygroscopic excipient nanoparticle aerosols
  publication-title: Aerosol Sci Technol
  doi: 10.1080/02786826.2011.566592
  contributor:
    fullname: Hindle
– volume: 64
  start-page: 1254
  year: 2012
  end-page: 1263
  ident: CR45
  article-title: Condensational growth of combination drug-excipient submicrometer particles for targeted high-efficiency pulmonary delivery: evaluation of formulation and delivery device
  publication-title: J Pharm Pharmacol
  doi: 10.1111/j.2042-7158.2012.01476.x
  contributor:
    fullname: Longest
– year: 1994
  ident: CR33
  publication-title: Human respiratory tract model for radiological protection
– volume: 443
  start-page: 137
  year: 2013
  end-page: 145
  ident: CR35
  article-title: Aerosolization characteristics of dry powder inhaler formulations for the excipient enhanced growth (EEG) application: effect of spray drying process conditions on aerosol performance
  publication-title: Int J Pharm
  doi: 10.1016/j.ijpharm.2013.01.003
  contributor:
    fullname: Hindle
– ident: CR5
– volume: 51
  start-page: 75
  year: 1996
  end-page: 77
  ident: CR10
  article-title: In vitro assessment of drug delivery through an endotracheal tube using a dry powder inhaler delivery system
  publication-title: Thorax
  doi: 10.1136/thx.51.1.75
  contributor:
    fullname: LeSouef
– volume: 59
  start-page: 686
  year: 2014
  end-page: 698
  ident: CR22
  article-title: Improving aerosol drug delivery during invasive mechanical ventilation with redesigned components
  publication-title: Respir Care
  doi: 10.4187/respcare.02782
  contributor:
    fullname: Hindle
– volume: 43
  start-page: 808
  year: 2009
  end-page: 827
  ident: CR31
  article-title: Characterization of submicrometer aerosol deposition in extrathoracic airways during nasal exhalation
  publication-title: Aerosol Sci Technol
  doi: 10.1080/02786820902950887
  contributor:
    fullname: Longest
– volume: 100
  start-page: 721
  year: 2006
  end-page: 728
  ident: CR34
  article-title: Nebulization associated with bi-level noninvasive ventilation: analysis of pulmonary radioaerosol deposition
  publication-title: Respir Med
  doi: 10.1016/j.rmed.2005.07.012
  contributor:
    fullname: Parreira
– ident: CR28
– volume: 51
  start-page: 5562
  year: 2008
  end-page: 5577
  ident: CR30
  article-title: Numerical predictions of submicrometer aerosol deposition in the nasal cavity using a novel drift flux approach
  publication-title: Int J Heat Mass Transf
  doi: 10.1016/j.ijheatmasstransfer.2008.04.037
  contributor:
    fullname: Longest
– volume: 46
  start-page: 514
  year: 2012
  end-page: 520
  ident: CR4
  article-title: Deposition of dry powder generated by solovent in Sophia anatomical infant nose-throat (SAINT) model
  publication-title: Aerosol Sci Technol
  doi: 10.1080/02786826.2011.643257
  contributor:
    fullname: Powell
– volume: 58
  start-page: 98
  year: 2013
  end-page: 120
  ident: CR13
  article-title: High-flow oxygen administration by nasal cannula for adult and perinatal patients
  publication-title: Respir Care
  doi: 10.4187/respcare.01941
  contributor:
    fullname: Ward
– volume: 28
  start-page: 189
  year: 2015
  ident: 2473_CR8
  publication-title: J Aerosol Med Pulm Drug Deliv.
  doi: 10.1089/jamp.2014.1158
  contributor:
    fullname: PW Longest
– volume: 2
  start-page: 365
  year: 1989
  ident: 2473_CR25
  publication-title: J Aerosol Med
  doi: 10.1089/jam.1989.2.365
  contributor:
    fullname: RA Guilmette
– ident: 2473_CR18
  doi: 10.1002/ppul.23123
– volume: 443
  start-page: 137
  year: 2013
  ident: 2473_CR35
  publication-title: Int J Pharm
  doi: 10.1016/j.ijpharm.2013.01.003
  contributor:
    fullname: Y-J Son
– volume: 45
  start-page: 884
  year: 2011
  ident: 2473_CR42
  publication-title: Aerosol Sci Technol
  doi: 10.1080/02786826.2011.566592
  contributor:
    fullname: PW Longest
– volume: 2
  start-page: 639
  year: 2018
  ident: 2473_CR41
  publication-title: Respiratory Drug Delivery
  contributor:
    fullname: ST Boc
– ident: 2473_CR6
  doi: 10.1089/jamp.2017.1424
– volume: 317
  start-page: 64
  year: 1981
  ident: 2473_CR9
  publication-title: Lancet
  doi: 10.1016/S0140-6736(81)90002-7
  contributor:
    fullname: CJ Morley
– volume: 58
  start-page: 98
  year: 2013
  ident: 2473_CR13
  publication-title: Respir Care
  doi: 10.4187/respcare.01941
  contributor:
    fullname: JJ Ward
– volume: 25
  start-page: 63
  year: 2012
  ident: 2473_CR16
  publication-title: J Aerosol Med Pulm Drug Deliv.
  doi: 10.1089/jamp.2011.0929
  contributor:
    fullname: R Dhand
– volume: 30
  start-page: 2917
  year: 2013
  ident: 2473_CR24
  publication-title: Pharm Res
  doi: 10.1007/s11095-013-1123-3
  contributor:
    fullname: L Golshahi
– volume: 26
  start-page: 248
  year: 2013
  ident: 2473_CR44
  publication-title: J Aerosol Med Pulm Drug Deliv
  doi: 10.1089/jamp.2012.0997
  contributor:
    fullname: G Tian
– ident: 2473_CR28
– volume: 30
  start-page: 100
  year: 2017
  ident: 2473_CR7
  publication-title: J Aerosol Med Pulm Drug Deliv.
  doi: 10.1089/jamp.2016.1320
  contributor:
    fullname: B Feng
– volume: 38
  start-page: 1063
  year: 2004
  ident: 2473_CR26
  publication-title: Aerosol Sci Technol
  doi: 10.1080/027868290883360
  contributor:
    fullname: JT Kelly
– volume: 46
  start-page: 514
  year: 2012
  ident: 2473_CR4
  publication-title: Aerosol Sci Technol
  doi: 10.1080/02786826.2011.643257
  contributor:
    fullname: BL Laube
– ident: 2473_CR5
  doi: 10.1016/j.ijpharm.2018.05.011
– volume: 30
  start-page: 223
  year: 2017
  ident: 2473_CR37
  publication-title: J Aerosol Med Pulm Drug Deliv.
  doi: 10.1089/jamp.2016.1333
  contributor:
    fullname: KL Zeman
– volume: 41
  start-page: 1217
  year: 2013
  ident: 2473_CR20
  publication-title: Ann Biomed Eng
  doi: 10.1007/s10439-013-0759-9
  contributor:
    fullname: PW Longest
– volume: 21
  start-page: 181
  year: 2008
  ident: 2473_CR15
  publication-title: J Aerosol Med Pulm Drug Deliv.
  doi: 10.1089/jamp.2007.0662
  contributor:
    fullname: AR Bhashyam
– volume-title: Human respiratory tract model for radiological protection
  year: 1994
  ident: 2473_CR33
  contributor:
    fullname: ICRP
– volume: 51
  start-page: 5562
  year: 2008
  ident: 2473_CR30
  publication-title: Int J Heat Mass Transf
  doi: 10.1016/j.ijheatmasstransfer.2008.04.037
  contributor:
    fullname: J Xi
– volume: 59
  start-page: 686
  year: 2014
  ident: 2473_CR22
  publication-title: Respir Care
  doi: 10.4187/respcare.02782
  contributor:
    fullname: PW Longest
– volume: 38
  start-page: 1072
  year: 2004
  ident: 2473_CR27
  publication-title: Aerosol Sci Technol
  doi: 10.1080/027868290883432
  contributor:
    fullname: JT Kelly
– volume: 48
  start-page: 434
  year: 2014
  ident: 2473_CR43
  publication-title: Aerosol Sci Technol
  doi: 10.1080/02786826.2014.887829
  contributor:
    fullname: G Tian
– volume: 24
  start-page: 103
  year: 2011
  ident: 2473_CR21
  publication-title: J Aerosol Med Pulm Drug Deliv
  doi: 10.1089/jamp.2010.0849
  contributor:
    fullname: PW Longest
– volume: 43
  start-page: 808
  year: 2009
  ident: 2473_CR31
  publication-title: Aerosol Sci Technol
  doi: 10.1080/02786820902950887
  contributor:
    fullname: J Xi
– volume: 30
  start-page: 190
  year: 2017
  ident: 2473_CR11
  publication-title: J Aerosol Med Pulm Drug Deliv.
  doi: 10.1089/jamp.2016.1343
  contributor:
    fullname: RL Walenga
– volume: 100
  start-page: 721
  year: 2006
  ident: 2473_CR34
  publication-title: Respir Med
  doi: 10.1016/j.rmed.2005.07.012
  contributor:
    fullname: EET Franca
– ident: 2473_CR3
  doi: 10.1089/jamp.2010.0825
– volume: 103
  start-page: 465
  year: 2014
  ident: 2473_CR38
  publication-title: J Pharm Sci
  doi: 10.1002/jps.23775
  contributor:
    fullname: SRB Behara
– volume: 43
  start-page: 2804
  year: 2015
  ident: 2473_CR39
  publication-title: Ann Biomed Eng
  doi: 10.1007/s10439-015-1335-2
  contributor:
    fullname: DR Farkas
– volume: 31
  start-page: 360
  year: 2014
  ident: 2473_CR23
  publication-title: Pharm Res
  doi: 10.1007/s11095-013-1165-6
  contributor:
    fullname: SRB Behara
– volume: 35
  start-page: 560
  year: 2007
  ident: 2473_CR32
  publication-title: Ann Biomed Eng
  doi: 10.1007/s10439-006-9245-y
  contributor:
    fullname: J Xi
– volume: 30
  start-page: 349
  year: 2017
  ident: 2473_CR36
  publication-title: Journal of Aerosol Medicine and Pulmonary Drug Delivery.
  doi: 10.1089/jamp.2017.1366
  contributor:
    fullname: J Dugernier
– volume: 465
  start-page: 52
  year: 2014
  ident: 2473_CR1
  publication-title: Int J Pharm
  doi: 10.1016/j.ijpharm.2014.01.043
  contributor:
    fullname: SRB Behara
– volume: 462
  start-page: 19
  year: 2014
  ident: 2473_CR2
  publication-title: Int J Pharm
  doi: 10.1016/j.ijpharm.2013.12.030
  contributor:
    fullname: W Pornputtapitak
– volume: 20
  start-page: S85
  year: 2007
  ident: 2473_CR14
  publication-title: J Aerosol Med
  doi: 10.1089/jam.2007.0574
  contributor:
    fullname: DR Hess
– volume: 14
  start-page: E250
  year: 2013
  ident: 2473_CR17
  publication-title: Pediatr Crit Care Med
  doi: 10.1097/PCC.0b013e31828a7f79
  contributor:
    fullname: SA Perry
– volume: 2
  start-page: 635
  year: 2018
  ident: 2473_CR40
  publication-title: Respiratory Drug Delivery
  contributor:
    fullname: ST Boc
– volume: 51
  start-page: 75
  year: 1996
  ident: 2473_CR10
  publication-title: Thorax
  doi: 10.1136/thx.51.1.75
  contributor:
    fullname: ML Everard
– volume: 64
  start-page: 1254
  year: 2012
  ident: 2473_CR45
  publication-title: J Pharm Pharmacol
  doi: 10.1111/j.2042-7158.2012.01476.x
  contributor:
    fullname: M Hindle
– volume: 533
  start-page: 187
  year: 2017
  ident: 2473_CR12
  publication-title: Int J Pharm
  doi: 10.1016/j.ijpharm.2017.08.079
  contributor:
    fullname: T Okuda
– ident: 2473_CR19
– volume: 19
  start-page: 301
  year: 2006
  ident: 2473_CR29
  publication-title: J Aerosol Med.
  doi: 10.1089/jam.2006.19.301
  contributor:
    fullname: JD Schroeter
SSID ssj0008194
Score 2.4294171
Snippet Purpose To demonstrate efficient aerosol delivery through an in vitro nasal model using a dry powder inhaler (DPI) requiring low actuation air volumes (LV)...
To demonstrate efficient aerosol delivery through an in vitro nasal model using a dry powder inhaler (DPI) requiring low actuation air volumes (LV) applied...
Purpose To demonstrate efficient aerosol delivery through an in vitro nasal model using a dry powder inhaler (DPI) requiring low actuation air volumes (LV)...
PurposeTo demonstrate efficient aerosol delivery through an in vitro nasal model using a dry powder inhaler (DPI) requiring low actuation air volumes (LV)...
PURPOSETo demonstrate efficient aerosol delivery through an in vitro nasal model using a dry powder inhaler (DPI) requiring low actuation air volumes (LV)...
SourceID pubmedcentral
proquest
gale
crossref
pubmed
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 194
SubjectTerms Administration, Inhalation
Aerosols
Biochemistry
Biomedical and Life Sciences
Biomedical Engineering and Bioengineering
Biomedicine
Chemistry, Pharmaceutical
Computer simulation
Dry Powder Inhalers - instrumentation
Equipment Design
Inhalation Spacers
Inhalers
Lung - anatomy & histology
Lungs
Medical Law
Medical materials
Nasal Sprays
Nose
Nose - anatomy & histology
Oxygen - chemistry
Particle Size
Pharmacology/Toxicology
Pharmacy
Powder
Powders - chemistry
Research Paper
Respiration
Respiratory therapy
SummonAdditionalLinks – databaseName: SpringerLINK - Czech Republic Consortium
  dbid: AGYKE
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB6V7YULlGdDCzISKhLUq8SPeHOM6JYWSrVCLSoHFDmJI6pWCepmhZZfz9h5sQsceo6VjD0zn8eemS8Ar3gutdZM0kKoggqpBdW-ENT4nGtZZFHuqio_nYZH5-LDhbzYANZfXZRX4y4j6YB66HULfNtMHKBiheJU3YFNafm-RrAZv__6cdrjL-5xjjRKMYG-LoIul_mvl6zsRuuY_MemtF4wuZY1dZvR4f2mQXDuOAxtDcrVeFGn4-zX3wyPt5jnFtxrY1MSN8b0ADZM-RD2Zg259XKfnA29WvN9skdmA-318hF8mzo2CpSdnFZzQ-uKniCSkNjg1KtrcmCubQ3IktirX6JLcuxIOsjB7Jh8NrYgGcUkJ9VPEtumFmswJL68IV8cfj6G88Pp2bsj2v68gWYYg9RU5j5PMfw0TDIdhsUkQyT1TabQMhAzJlpqVnAeZkUQ5mERIU6khdHGzzOVydTnT2BUVqXZBoJRaRgpiaGj4cLIYsICnYpI-bmQeNpUHrzplJj8aDg6koGN2S5ngsuZ2OVMcPBrq-bE-i_qMtNtGwJ-yjJhJbGySXJ7D-TBbmcJSevY84TZ-Irh0Tvy4GX_GF3S5ll0aapFMwZlxJjAg6eN4fRycZfb8lEMtWJS_QBL9736pLz87mi_FUO8lIEHbzvDGcT673Sf3Wr0Dtxl1vJcseIujOqbhXmOQVedvmi97DceQiJc
  priority: 102
  providerName: Springer Nature
Title Efficient Nose-to-Lung Aerosol Delivery with an Inline DPI Requiring Low Actuation Air Volume
URI https://link.springer.com/article/10.1007/s11095-018-2473-7
https://www.ncbi.nlm.nih.gov/pubmed/30132207
https://www.proquest.com/docview/2091029789
https://search.proquest.com/docview/2091821123
https://pubmed.ncbi.nlm.nih.gov/PMC7253151
Volume 35
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELfY-sILYnwGRmUkNCSYpcQfcfOEAuvYYFTVtKLygCInscWkKdnWTqj_PXdO0tBK8JpY8iW_-7B9dz8T8kaUyhjDFXNSOyaVkcyEUjIbCmGUK5LSV1V-m8QnM_llrubtgduiLavsfKJ31GVd4Bk5bNIhsHHY8yQfrm8Y3hqF2dX2Co0dMuCRxDTt4ON4Mj1f-2KId55ASnMJdi-jLq_pm-eiELuTI9AUqQXTG5Fp2z__FaC2iye3Mqg-MB0_JA_aFSVNGxXYI_ds9YgcTBtK6tUhveg7rBaH9IBOe7Lq1WPyc-w5JGAWOqkXli1rdgb2T1MLQtZX9MheYeXGiuKBLTUVPfXUGvRoekrPLZYRg1D0rP5NU2xFQZhpenlLv3uv94TMjscXn05Ye-UCK2DlsGSqDEUOi0bLFTdx7EYF-L_QFhrwBEsfGWW4EyIuXBSXsUvAunNnjQ3LQhcqD8VTslvVlX1OKKwl40QrQMUKaZUb8cjkMtFhKRXsEXVA3nW_O7tumDWynkMZsckAmwyxyWDwWwQkQ6uDv16YtnkApkL-qizVmNrG05uA7HeYZa05LrJeeQLyev0aDAmzI6ay9V0zBmSESB6QZw3Ea7mEz0iFIIbeAH89AEm6N99Ul788Wbfm4OVUFJD3nZr0Yv3zc1_8_yNekvsc9dbXFO6T3eXtnX0Fa6NlPiQ7eq6HZJB-_vF1PGzNAZ7OePoHa3wOuw
link.rule.ids 230,315,786,790,891,12083,21416,27955,27956,31752,31753,33777,33778,41114,41556,42183,42625,43343,43838,52144,52267,74100,74657
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ba9swFBZb97C9jHVXr5dpMDrYKpAtyYqfhumFZEtDGOnIyxCyLbNCsdsmZeTf7xzZjpfA9myBj_2dm3TO-UTIB1Eoa22kWCl1yaSyklkuJXNcCKvKPCl8V-XFJB5eyq9zNW8P3BZtW2XnE72jLuocz8hhkw6BLYI9T_Ll5pbhrVFYXW2v0HhIHkkhJOq5nq83XBjtPH2UjiRYvQy7qqYfnQs5ziaHoCdSC6Y34tK2d_4rPG23Tm7VT31YOn9Gnrb5JE0bBdglD1z1nBxNG0Lq1TGd9fNVi2N6RKc9VfXqBfl55hkk4C10Ui8cW9ZsDNZPUwdC1tf01F1j38aK4nEttRUdeWINejod0e8Om4hBKDquf9MUB1EQZJpe3dEf3ue9JJfnZ7OTIWsvXGA55A1LpgouMkgZXaQiG8flIAfvx12uAU2w84FVNiqFiPMyjIu4TMC2s9JZx4tc5yrj4hXZqerKvSEUMsk40QrSPSekU-UgCm0mE80LqWCHqAPyqfvd5qbh1TA9gzJiYwAbg9gYWPwRATFoc_DXc9uODsCrkL3KpBoL23h2E5D9DjPTGuPC9KoTkPfrx2BGWBuxlavvmzUgI8TxgLxuIF7LJXw9ioMYegP89QKk6N58Ul398lTdOgIfp8KAfO7UpBfrn5_79v8f8Y48Hs4uxmY8mnzbI08i1GHfXbhPdpZ39-4AsqRlduhN4Q-TvAze
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELdgSIgXxDcZA4yEhgSzcGI7bp5QRFetUKoKbagvyHITW0yakm3thPrfc-ckDa0Ez7GUS373Zd_dz4S8FaWy1iaKeak9k8pKZrmUzHEhrPJFVoauym_T9ORMfpmredv_tGzbKjufGBx1WRd4Rg6bdAhsCex5so--bYuYDUefLq8Y3iCFldb2Oo3b5A5ESY7XOOj5ZvOFkS9QSelEggeQcVfhDGN0Mcc55Rh0RmrB9FaM2vXUf4Wq3TbKnVpqCFGjB-R-m1vSvFGGh-SWqx6Rw1lDTr0-oqf9rNXyiB7SWU9bvX5Mfh4HNgl4C53WS8dWNZuAJ6C5AyHrCzp0F9jDsaZ4dEttRceBZIMOZ2P63WFDMQhFJ_VvmuNQCgJO8_Nr-iP4vyfkbHR8-vmEtZcvsAJyiBVTJRcLSB9dohKbpn5QgCfkrtCALNj8wCqbeCHSwsdpmfoM7HzhnXW8LHShFlw8JXtVXbnnhEJWmWZaQernhHTKD5LYLmSmeSkV7BZ1RN53v9tcNhwbpmdTRmwMYGMQGwOL3yEgBu0P_nph2zECeBUyWZlcY5Ebz3EictBhZlrDXJpejSLyZvMYTArrJLZy9U2zBmSEmB6RZw3EG7lEqE1xEENvgb9ZgHTd20-q81-Btlsn4O9UHJEPnZr0Yv3zc_f__xGvyV2wAjMZT7--IPcSVOHQaHhA9lbXN-4lJEyrxatgCX8ASIMRCg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Efficient+Nose-to-Lung+Aerosol+Delivery+with+an+Inline+DPI+Requiring+Low+Actuation+Air+Volume&rft.jtitle=Pharmaceutical+research&rft.au=Farkas%2C+Dale&rft.au=Hindle%2C+Michael&rft.au=P+Worth+Longest&rft.date=2018-10-01&rft.pub=Springer+Nature+B.V&rft.issn=0724-8741&rft.eissn=1573-904X&rft.volume=35&rft.issue=10&rft.spage=1&rft.epage=12&rft_id=info:doi/10.1007%2Fs11095-018-2473-7&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0724-8741&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0724-8741&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0724-8741&client=summon